Healthcare provider profile · identity verified

Pernell Joseph Simon, MD

Family Practice · LAFAYETTE, LA · NPI 1699878124

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Alprazolam	Alprazolam	249	44
Amlodipine Besylate	Amlodipine Besylate	234	61
Atorvastatin Calcium	Atorvastatin Calcium	223	59
Levothyroxine Sodium	Levothyroxine Sodium	204	54
Lisinopril	Lisinopril	164	44
Losartan Potassium	Losartan Potassium	163	40
Metformin Hcl	Metformin Hcl	158	40
Rosuvastatin Calcium	Rosuvastatin Calcium	156	44
Sertraline Hcl	Sertraline Hcl	151	34
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	116	25
Pantoprazole Sodium	Pantoprazole Sodium	114	34
Omeprazole	Omeprazole	109	28
Zolpidem Tartrate	Zolpidem Tartrate	109	20
Tramadol Hcl	Tramadol Hcl	106	21
Tamsulosin Hcl	Tamsulosin Hcl	95	23
Gabapentin	Gabapentin	82	22
Hydrochlorothiazide	Hydrochlorothiazide	80	20
Glipizide Er	Glipizide	66	15
Allopurinol	Allopurinol	63	15
Meloxicam	Meloxicam	63	13
Pioglitazone Hcl	Pioglitazone Hcl	63	14
Metoprolol Succinate	Metoprolol Succinate	61	17
Celecoxib	Celecoxib	59	12
Venlafaxine Hcl Er	Venlafaxine Hcl	56	12
Pravastatin Sodium	Pravastatin Sodium	54	17
Fluticasone Propionate	Fluticasone Propionate	53	16
Finasteride	Finasteride	52	11
Trazodone Hcl	Trazodone Hcl	52	13
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	51	12
Metformin Hcl Er	Metformin Hcl	50	12
Montelukast Sodium	Montelukast Sodium	50	11
Clonazepam	Clonazepam	49	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	48	12
Albuterol Sulfate Hfa	Albuterol Sulfate	47	16
Mounjaro	Tirzepatide	46	suppressed
Ozempic	Semaglutide	46	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	45	15
Telmisartan	Telmisartan	44	14
Pregabalin	Pregabalin	43	suppressed
Buspirone Hcl	Buspirone Hcl	41	suppressed
Furosemide	Furosemide	39	15
Fluoxetine Hcl	Fluoxetine Hcl	37	13
Triamcinolone Acetonide	Triamcinolone Acetonide	35	18
Azithromycin	Azithromycin	34	27
Lorazepam	Lorazepam	34	suppressed
Duloxetine Hcl	Duloxetine Hcl	30	suppressed
Paroxetine Hcl	Paroxetine Hcl	30	suppressed
Potassium Chloride	Potassium Chloride	30	suppressed
Atenolol	Atenolol	27	suppressed
Glimepiride	Glimepiride	27	suppressed
Jardiance	Empagliflozin	27	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	27	suppressed
Prednisone	Prednisone	27	13
Ropinirole Hcl	Ropinirole Hcl	27	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	26	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	25	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	25	suppressed
Chlorthalidone	Chlorthalidone	24	suppressed
Clopidogrel	Clopidogrel Bisulfate	24	suppressed
Ezetimibe	Ezetimibe	23	suppressed
Valacyclovir	Valacyclovir Hcl	23	suppressed
Eszopiclone	Eszopiclone	22	suppressed
Meclizine Hcl	Meclizine Hcl	22	suppressed
Diclofenac Sodium	Diclofenac Sodium	21	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	21	13
Olmesartan Medoxomil	Olmesartan Medoxomil	21	suppressed
Citalopram Hbr	Citalopram Hydrobromide	19	suppressed
Irbesartan	Irbesartan	19	suppressed
Levetiracetam	Levetiracetam	19	suppressed
Mupirocin	Mupirocin	19	suppressed
Synthroid	Levothyroxine Sodium	19	suppressed
Benazepril Hcl	Benazepril Hcl	18	suppressed
Bupropion Xl	Bupropion Hcl	18	suppressed
Donepezil Hcl	Donepezil Hcl	18	suppressed
Estradiol	Estradiol	18	suppressed
Ramipril	Ramipril	18	suppressed
Breo Ellipta	Fluticasone/Vilanterol	17	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	17	suppressed
Ondansetron Odt	Ondansetron	17	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	16	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	16	suppressed
Glipizide	Glipizide	16	suppressed
Lovastatin	Lovastatin	16	suppressed
Nifedipine Er	Nifedipine	16	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	16	13
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	15	suppressed
Simvastatin	Simvastatin	15	suppressed
Indomethacin	Indomethacin	14	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	14	suppressed
Januvia	Sitagliptin Phosphate	14	suppressed
Rizatriptan	Rizatriptan Benzoate	14	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	14	suppressed
Trulicity	Dulaglutide	14	suppressed
Armour Thyroid	Thyroid,pork	13	suppressed
Famotidine	Famotidine	13	suppressed
Fluconazole	Fluconazole	13	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	13	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	13	suppressed
Symbicort	Budesonide/Formoterol Fumarate	13	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	12	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	12	suppressed
Euthyrox	Levothyroxine Sodium	12	suppressed
Propafenone Hcl	Propafenone Hcl	12	suppressed
Propranolol Hcl	Propranolol Hcl	12	suppressed
Torsemide	Torsemide	12	suppressed
Ventolin Hfa	Albuterol Sulfate	12	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	11	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	11	suppressed
Azelastine Hcl	Azelastine Hcl	11	suppressed
Breyna	Budesonide/Formoterol Fumarate	11	suppressed
Eliquis	Apixaban	11	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	11	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	11	suppressed
Tizanidine Hcl	Tizanidine Hcl	11	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	11	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error